Navigation Links
Opsona Therapeutics Closes EUR18M Funding
Date:2/18/2009

cal development which modulate the innate immune system, including biologics and small molecules. The company has signed some significant partnering and collaborative deals, such as with Wyeth (USA). The company is based in Dublin and also has laboratories in Lausanne, Switzerland.

http://www.opsona.com

About Novartis Venture Fund

The Novartis Venture Fund, established in 1996 currently manages over $650 million in committed capital. NVF invests in companies which have the potential to change a core therapeutic field or explore new business areas that will be critical to patient care. Our primary interest is in the development of novel therapeutics and platforms as well as medical devices, diagnostics, and delivery systems. The Fund invests for financial objectives at all stages, but prefers to invest in the early-stages of company development. With eight investment professionals located in Basel, Switzerland and Cambridge, MA the team has extensive experience in pharmaceutical R&D and venture capital.

http://www.venturefund.novartis.com

About Fountain Healthcare Partners

Fountain Healthcare Partners ("Fountain") is a life science focused venture capital fund headquartered in Dublin, Ireland with a second office in New York, US. Fountain specialises in making investments in biotechnology, medical device, specialty pharma and diagnostic companies and allocates the majority of its capital to Europe with a primary emphasis on Ireland. Fountain launched its inaugural fund (Fountain Healthcare Partners I) in May 2008 with EUR75M in committed capital.

http://www.fh-partners.com

About Inventages

Inventages is one of the world's largest life-sciences, nutrition
'/>"/>

SOURCE Opsona Therapeutics Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... American Filtration and Separations Society will hold its 23rd Annual Technical ... Hotel in San Antonio, Texas. To further impact the separation society ... are proud to announce that the 2010 AFS Annual Technical Conference ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- ...
(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...
(Date:12/15/2009)... Force Microscopy (AFM) have been developed and are opening up ... interface. The NeedleProbes’ cylindrical geometry enables researchers to measure ... - all in a single force distance curve. , ... ... constant diameter NeedleProbes are enabling unique measurements at ...
(Date:12/15/2009)... 15 On January 20th, 2010, the ... Medical Publication Professionals (ISMPP) will be held at ... More than 100 attendees are expected at this ... professionals, editors, publishers, medical writers and medical agencies ... and the impact of guidelines and regulations such ...
Breaking Biology Technology:American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
... proof-of-concept for diagnosing Parkinson,s ... Foundation awards grant to Molecular Biometrics for further ... development of Parkinson,s diagnostic, CHESTER, ... June issue of the peer-reviewed journal, Biomarkers in Medicine,demonstrated proof-of-concept ...
... BNVI ) today announced results for the second ... did not report any revenue for the three and ... $7,500 for the three and six,months ended June 30, ... with a Taiwanese company. In October of 2007,we terminated ...
... 5 NeoStem, Inc. (Amex: NBS ),announced today that ... Gables, a suburb of Miami, is targeted to open in,September. ... CelVida,LLC. With the opening of this center, NeoStem has secured ... a large U.S. market as well as a,growing sophisticated South ...
Other Biology Technology:Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 2Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 3Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 4Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology 5Bionovo Reports Second Quarter 2008 Financial Results 2Bionovo Reports Second Quarter 2008 Financial Results 3Bionovo Reports Second Quarter 2008 Financial Results 4Bionovo Reports Second Quarter 2008 Financial Results 5Bionovo Reports Second Quarter 2008 Financial Results 6Bionovo Reports Second Quarter 2008 Financial Results 7NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide 2NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide 3
(Date:12/15/2009)... GenWay Clinical Laboratory, San Diego, California, has been ... Pathologists (CAP), based on results of a recent ... was advised of this national recognition and congratulated ... GenWay Biotech Inc. GenWay Clinical Laboratory is one ... CAP Laboratory Accreditation Program, begun in the early ...
(Date:12/15/2009)... 2006, a team of Spanish and American researchers found the ... Bonares, Huelva. Now they have published, for the first time, ... with the death of the young cetacean, possibly a baleen ... first discovery of the partial fossil remains of a whale ... Huelva Sands sedimentary formation, but it is the first time ...
(Date:12/15/2009)... a standard laboratory model organism, but there are ... analyze blood and blood-forming tissues in this species. ... easy-to-use laboratory resources from Cold Spring Harbor Laboratory ... features step-by-step protocols for the preparation, enumeration, ... and other hematopoietic tissues in the mouse. ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3New source of classical techniques for blood-based studies in the laboratory mouse 2Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 1Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 2Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico Turkey and Five Other Countries in Europe 5120 3Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 1Method to Identify Female Athletes at a High Risk for Knee Injury Discovered 58628 2Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2
... randomized clinical trial for patients with previously untreated ... spread from the breast to other parts of ... bevacizumab (Avastin? in combination with standard chemotherapy had ... than patients who received the same chemotherapy without ...
... Institute for OneWorld Health, the first nonprofit pharmaceutical company ... Drug Designation from the two leading regulatory agencies in ... the European Agency for the Evaluation of Medicinal Products ... VL, also known as kala azar ("black fever"), is ...
... in the ecological community to agree a set of ... being led by the British Ecological Society's Journal of ... profile on river restoration. Opening the debate is a ... criteria for ecologically successful river restoration. Their aim is ...
Other Biology News:Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 3OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2Putting ecology back into river restoration 2
... The S.c. EasyComp Transformation Kit ... transformation-competent Saccharomyces cerevisiae cells. Advantages over ... spheroplast formation or LiCl methods include:- Cells ... than 30 minutes - Competent cell preparation ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
... (100+kb), fosmid (40kb), and large plasmid insert ... othe BAC vector. On command 20-50 fold ... recombinant DNA purification. Available with blue-white screening ... for the highest insert stability. Kits include ...
Biology Products: